Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Drake

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
The Canadian Journal of Urology|August 22, 2016
Infectious complications in transfused patients after radical cystectomyJen-Jane Liu, Patrick Mullane, Max Kates, et al.
The Oncologist|February 12, 2020
A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell CarcinomaAndrew W Hahn, Charles Drake, Samuel R Denmeade, et al.
Urology|March 4, 2015
Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinomaSheila F Faraj, Enrico Munari, Gunes Guner, et al.
Nature Immunology|April 19, 2005
Egr-2 and Egr-3 are negative regulators of T cell activationMeredith Safford, Samuel Collins, Michael A Lutz, et al.
Oncoimmunology|July 29, 2016
The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladderAlexander S Baras, Charles Drake, Jen-Jane Liu, et al.
Immunology|March 24, 2022
Adoptive transfer of IL-4 reprogrammed Tc17 cells elicits anti-tumour immunity through functional plasticityChiung-Hui Liu, Bo-Shiou Lin, Mei-Yao Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 5, 2026
Metabolic Reprogramming of T Cells by Dual UCP2 and IL-17 Blockade Enhances Immunity Against Pancreatic CancerChuan-Teng Liu, Chun-Chieh Yeh, Tsai-Chen Wu, et al.
Human Pathology|April 27, 2019
Tumor immune microenvironment in non-muscle-invasive urothelial carcinoma of the bladderMarie-Lisa Eich, Alcides Chaux, Gunes Guner, et al.
Elife|November 20, 2024
Neurotrophic factor Neuritin modulates T cell electrical and metabolic state for the balance of tolerance and immunityHong Yu, Hiroshi Nishio, Joseph Barbi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2026
Molecular Characterization of KLK2 RNA Expression in Prostate CancerRana R McKay, Shayan S Nazari, Andrew Elliott, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Canadian Journal of Urology|August 22, 2016
Infectious complications in transfused patients after radical cystectomyJen-Jane Liu, Patrick Mullane, Max Kates, et al.
The Oncologist|February 12, 2020
A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell CarcinomaAndrew W Hahn, Charles Drake, Samuel R Denmeade, et al.
Urology|March 4, 2015
Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinomaSheila F Faraj, Enrico Munari, Gunes Guner, et al.
Nature Immunology|April 19, 2005
Egr-2 and Egr-3 are negative regulators of T cell activationMeredith Safford, Samuel Collins, Michael A Lutz, et al.
Oncoimmunology|July 29, 2016
The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladderAlexander S Baras, Charles Drake, Jen-Jane Liu, et al.
Immunology|March 24, 2022
Adoptive transfer of IL-4 reprogrammed Tc17 cells elicits anti-tumour immunity through functional plasticityChiung-Hui Liu, Bo-Shiou Lin, Mei-Yao Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 5, 2026
Metabolic Reprogramming of T Cells by Dual UCP2 and IL-17 Blockade Enhances Immunity Against Pancreatic CancerChuan-Teng Liu, Chun-Chieh Yeh, Tsai-Chen Wu, et al.
Human Pathology|April 27, 2019
Tumor immune microenvironment in non-muscle-invasive urothelial carcinoma of the bladderMarie-Lisa Eich, Alcides Chaux, Gunes Guner, et al.
Elife|November 20, 2024
Neurotrophic factor Neuritin modulates T cell electrical and metabolic state for the balance of tolerance and immunityHong Yu, Hiroshi Nishio, Joseph Barbi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2026
Molecular Characterization of KLK2 RNA Expression in Prostate CancerRana R McKay, Shayan S Nazari, Andrew Elliott, et al.
Pageof 3